GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Imexpharm Corp (STC:IMP) » Definitions » Other Financing

Imexpharm (STC:IMP) Other Financing : ₫-66,672 Mil (TTM As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Imexpharm Other Financing?

Imexpharm's Other Financing for the three months ended in Mar. 2024 was ₫0 Mil.

Imexpharm's Other Financing for the trailing twelve months (TTM) ended in Mar. 2024 was ₫-66,672 Mil.

Imexpharm Other Financing Historical Data

The historical data trend for Imexpharm's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imexpharm Other Financing Chart

Imexpharm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Imexpharm Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -66,671.57 -

Imexpharm Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫-66,672 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imexpharm Other Financing Related Terms

Thank you for viewing the detailed overview of Imexpharm's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Imexpharm (STC:IMP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Imexpharm Corp (STC:IMP) » Definitions » Other Financing
Comparable Companies
STC:TRA STC:DMC STC:DHG ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085 XPAR:IPN
Traded in Other Exchanges
N/A
Address
4 Road 30/04 Street Ward 1, Cao Lanh City, Dongthap, VNM
Website
http://www.imexpharm.com
Imexpharm Corp is engaged in the manufacture, import, export, and trade of pharmaceuticals and medicinal chemical products. Its products include oral and injective antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals.

Imexpharm (STC:IMP) Headlines

No Headlines